Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer

Oral Oncology

Volumn 46, Issue 5, 2010, Pages

  Lin, Jen Tsun ^a,e   Chang, Tung Hao ^b,c,d   Chang, Cheng Shong ^b   Wang, Wen Hong ^a   Su, Bi Wen ^a   Lee, Kuan Der ^a   Chang, Pey Jium ^e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d YUANPEI UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

CD44 mRNA; Head and neck cancer; Oral cancer; Quantitative RT PCR

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHILD; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; PERIPHERAL CIRCULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT RESPONSE;

ADULT; ANTIGENS, CD44; CELL LINE, TUMOR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77950938830     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.02.011     Document Type: Article

References (31)

1. Gunthert U., Stauder R., Mayer B., Terpe H., Finke L., and Friedrichs K. Are CD44 variant isoforms involved in human tumor progression?. Cancer Surv 24 1 (1995) 19-42
2. Iida N., and Bourguignon L.Y.W. New CD44 splice variants associated with human breast cancers. J Cell Physiol 162 2 (1995) 127-133
3. Bourguignon L.Y., Lokeshwar V.A., and He H. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol 12 6 (1992) 4464-4471
4. Kuhn S., Koch M., Nubel T., Ladwein M., and Antolovic D. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 5 3 (2007) 553-567
5. Bourguignon L.Y. Interactions between the membrane cytoskeleton and CD44 during lymphocyte signal transduction and cell adhesion. Curr Top Membr 43 2 (1996) 293-312
6. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., and Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61 5 (1990) 1303-1313
7. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 3 (2003) 3983-3998
8. Dalerba P., Dylla S.J., Park I.K., Liu R., and Wang X. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104 3 (2007) 10158-10163
9. Wright M.H., Calcagno A.M., Salcidol C.D., Carlsonl M.D., Ambudkar S.V., and Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10 1 (2008) 1-16
10. Hurt E.M., Kawasaki B.T., Klarmann G.J., Thomas S.B., and Farrar W.L. CD44+CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98 2 (2008) 756-765
11. Yang Z.F., Ho D.W., Ng M.N., Lau C.K., Yu W.C., Ngai P., et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13 2 (2008) 153-166
12. Li C.W., Heidt D.G., Dalerba P., Burant C.F., Zhang L.J., Adsay V., et al. Identification of pancreatic cancer stem cells. Cancer Res 67 3 (2007) 1030-1037
13. Collins A.T., Berry P.A., Hyde C., Stower M.J., and Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65 23 (2005) 10946-10951
14. Takaishi S., Okumura T., Tu S.P., Wang S.W., Shibata W., Vigneshwaran R., et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27 2 (2009) 1006-1020
15. Prince M.E., and Ailles L.E. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 26 5 (2008) 2871-2875
16. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., and Kaplan M.J. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo 22 5 (2007) 89-92
17. Guzman M.L., and Jordan C.T. Cancer stem cells. N Engl J Med 21 4 (2006) 1253-1261
18. Nagano O., and Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 95 3 (2004) 930-940
19. Cheng C., and Sharp P.A. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol 26 (2006) 362-370
20. Reategui E.R., de Mayolo A.A., Das P.M., Astor F.C., Singal R., Hamilton K.L., et al. Characterization of CD44v3-containing isoforms in head and neck cancer. Cancer Biol Ther 5 1 (2006) 1163-1168
21. Liu Y.J., Yan P.S., Li J., and Jia J.-F. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol 11 3 (2005) 6601-6606
22. Franzmann E.J., Reategui E.F., Carraway K.L., Hamilton K.J., Weed D.T., and Goodwin W.J. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 14 4 (2005) 735-739
23. Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184 2 (1993) 47-63
24. VanHal N.L.W., Van Dongen G.A.M.S., Stigter-Vanwaasum M., Snow G.B., and Brakenhoff R.H. Characterization of CD44v6 isoforms in head-and-neck squamous cell carcinoma. Int J Cancer 82 6 (1999) 837-845
25. Patrawala L., Calhoun T., and Schneider-Broussard R. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25 4 (2006) 1696-1708
26. Li C., Heidt D.G., and Dalerba P. Identification of pancreatic cancer stem cells. Cancer Res 67 3 (2007) 1030-1037
27. Liu S., Dontu G., and Mantle I.D. Hedgehog signaling and Bmi-1regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66 5 (2006) 6063-6071
28. Jordan C.T., Guzman M.L., and Noble M. Cancer stem cells. N Engl J Med 355 5 (2006) 1253-1261
29. Huang Z.H., Li L.H., and Huang D. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett 243 3 (2006) 64-70
30. Xenidis N., Perraki M., Kafousi M., Apostolaki S., Bolonaki I., Stathopoulou A., et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol 24 5 (2006) 3756-3762
31. Mehra N., Penning M., Maas J., Beerepoot L.V., van Daal N., van Gils C.H., et al. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin Cancer Res 12 3 (2006) 4859-4866